Feedback / Questions
ETX-636 - Ensem Therap
https://www.businesswire.com/news/home/20260202247387/en/Ensem-Therapeutics-Doses-First-Patient-in-China-in-ETX-636-Global-Phase-12-Study
Feb 2, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next